Featured
Read our handpicked blogs, curated for you.
|
The Enforcement Horizon: August 2, 2026The industry consensus is dominated by the EU AI Act. As of mid-2026, AI systems…
|
The 2026 Industry Consensus: From Policies to EnforcementThe prevailing consensus among global Tier-1 banks is the…
|
The 2026 Industry Consensus: Unified Systems OrchestrationThe prevailing consensus in 2026 is that "more models…
Recent releases
|
Cutting Pharma Content Approval Cycles with Modular Ops
Every pharma marketer in India knows the feeling. A new campaign is planned, deadlines are set, and the brand team is ready to move. Then the medical-legal-regulatory (MLR) process begins. Weeks go…
|
The UCPMP 2024 Rulebook- What Pharma CMOs Need to Change in Marketing Ops
For years, Indian pharma operated in a grey zone where marketing practices were loosely monitored. That time is over. The UCPMP 2024 Rulebook (Uniform Code of Pharmaceutical Marketing Practices) has…
|
Why Indian Pharma Keeps Failing at Digital Transformation
Digital Transformation is the buzzword that never dies in Indian pharma boardrooms. Every annual strategy deck promises it. Every leadership summit talks about it. Yet when you look closely, most…
|
Omnichannel in Indian Pharma Beyond Emails and Rep Visits
The term omnichannel in Indian pharma gets thrown around so often that it risks losing meaning. Many companies believe they are already running omnichannel because they send emails, host a webinar or…
